CREKA peptide acetate
Product Specifications
Target
Others
Related Pathways
Others
Bioactivity
CREKA peptide acetate, a self-assembling short peptide (sequence Cys-Arg-Glu-Lys-Ala), specifically recognizes and binds to overexpressed fibrin, effectively targeting disease sites such as cancer, myocardial ischemia-reperfusion, and atherosclerosis. CREKA peptide acetate holds potential for research in the field of nanomedicine technology.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
